Last update :
28/04/2024
References   References 4068  
Type : Manufacturer

Research teams :
Authors :
Title : Natalizumab (Tysabri®) - Summary of Product Characteristics
Reference : Biogen Idec Ltd 2018

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionNatalizumab Immunosuppressant
Stability in solutions Not specified Sodium chloride 0,9% 2,6 mg/mL 2-8°C Not specified
8 Hour

  Mentions Légales